Dataset Information
HNE-modification identification of ApoAI
Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Blood Plasma
DISEASE(S): Cardiovascular System Disease
SUBMITTER: 
Claire Chang
LAB HEAD: Ching-Yu Lin
PROVIDER: PXD041969 | Pride | 2024-07-03
REPOSITORIES: Pride
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| AE-11_140403.raw | Raw | |||
| AE-11_140403.xml | Xml | |||
| AE-12_140403.raw | Raw | |||
| AE-12_140403.xml | Xml | |||
| AE-1_140403.raw | Raw |
Items per page: 1 - 5 of 18 |
Publications
Low Levels of IgM Recognizing 4-Hydroxy-2-Nonenal-Modified Apolipoprotein A-I Peptide and Its Association with the Severity of Coronary Artery Disease in Taiwanese Patients.
Current issues in molecular biology 20240620 6
Autoantibodies against apolipoprotein A-I (ApoA-I) are associated with cardiovascular disease risks. We aimed to examine the 4-hydroxy-2-nonenal (HNE) modification of ApoA-I in coronary artery disease (CAD) and evaluate the potential risk of autoantibodies against their unmodified and HNE-modified peptides. We assessed plasma levels of ApoA-I, HNE-protein adducts, and autoantibodies against unmodified and HNE-peptide adducts, and significant correlations and odds ratios (ORs) were examined. Two ...[more]
